0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint |  May 13, 2013 ONLINE FIRST
Adulterated Sexual Enhancement Supplements:  More Than Mojo
Pieter A. Cohen, MD; Bastiaan J. Venhuis, PhD
JAMA Intern Med. 2013;():1-3. doi:10.1001/jamainternmed.2013.854.
Correction |  May 13, 2013
Error in Table in: Communication and Medication Refill Adherence: The Diabetes Study of Northern California
JAMA Intern Med. 2013;173(9):731. doi:10.1001/jamainternmed.2013.6768.
Editorial |  April 22, 2013 ONLINE FIRST
Trust in the Medical Literature—and Viewpoints in JAMA Internal Medicine
Robert Steinbrook, MD; Rita F. Redberg, MD, MSc
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.6281.
Viewpoint |  April 22, 2013 ONLINE FIRST
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Intern Med. 2013;():1-2. doi:10.1001/jamainternmed.2013.823.
Research Letters |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
JAMA Intern Med. 2013;173(7):586-588. doi:10.1001/jamainternmed.2013.2797.
INCLUDES: , Supplemental Content
Research Letters |  April 08, 2013
Benefits of Participation in Diabetes Group Visits After Trial Completion
George L. Jackson, PhD, MHA; David Edelman, MD, MHS; Maren K. Olsen, PhD; et al.
JAMA Intern Med. 2013;173(7):590-592. doi:10.1001/jamainternmed.2013.2803.
INCLUDES: , Supplemental Content
Original Investigation |  April 08, 2013
Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus:  A Population-Based Matched Case-Control Study
Sonal Singh, MD, MPH; Hsien-Yen Chang, PhD; Thomas M. Richards, MS; et al.
JAMA Intern Med. 2013;173(7):534-539. doi:10.1001/jamainternmed.2013.2720.
INCLUDES: , Supplemental Content
Invited Commentary |  April 08, 2013
Glucagonlike Peptide 1–Based Drugs and Pancreatitis:  Clarity at Last, but What About Pancreatic Cancer?
Comment on “Glucagonlike Peptide 1–Based Therapies and Risk of Hospitalization for Acute Pancreatitis in Type 2 Diabetes Mellitus”
Belinda Gier, PhD; Peter C. Butler, MD
JAMA Intern Med. 2013;173(7):539-541. doi:10.1001/jamainternmed.2013.3374.
In This Issue of JAMA Internal Medicine |  March 11, 2013
In This Issue of JAMA Internal Medicine
JAMA Intern Med. 2013;173(5):333. doi:10.1001/jamainternmed.2013.2704.
Research Letters |  March 11, 2013
The Status of Baby Boomers' Health in the United States:  The Healthiest Generation?
Dana E. King, MD, MS; Eric Matheson, MD, MS; Svetlana Chirina, MPH; et al.
JAMA Intern Med. 2013;173(5):385-386. doi:10.1001/jamainternmed.2013.2006.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Small Case Series  |  May 2, 2013
Intravitreal Fasudil Combined With Bevacizumab for Persistent Diabetic Macular Edema: A Novel Treatment
Hamid Ahmadieh, MD; Ramin Nourinia, MD; Ali Hafezi-Moghadam, MD, PhD
JAMA
News From the Centers for Disease Control and Prevention  |  May 01, 2013
Few Adults With Prediabetes Know About Their Condition
JAMA
Health Agencies Update  |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
JAMA Ophthalmology
Clinical Sciences  |  April 18, 2013
Macular Edema After Cataract Surgery in Eyes Without Preoperative Central-Involved Diabetic Macular Edema
Diabetic Retinopathy Clinical Research Network*
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems